Does a high arachidonic acid-to-EPA ratio indicate a more AA-skewed precursor balance?

Arachidonic acid (AA) and eicosapentaenoic acid (EPA) are membrane fatty-acid precursors that can enter overlapping cyclooxygenase and lipoxygenase pathways. The AA:EPA ratio is therefore best understood as a compartment-specific marker of relative precursor balance, rather than a direct inflammation test.

Mechanistic and clinical interpretation

• A high AA:EPA ratio indicates relatively greater AA than EPA substrate in the blood or tissue compartment measured. AA can generate 2-series prostaglandins/thromboxanes and 4-series leukotrienes; EPA can generate 3-series prostanoids, 5-series leukotrienes, HEPEs, and intermediates relevant to E-series resolvin pathways.
• Human intervention findings support this directional interpretation. In a 12-week randomized trial, EPA-rich oil increased erythrocyte EPA and lowered erythrocyte AA:EPA versus control, accompanied by lower basal skin PGE2 and greater UV-induced 12-HEPE. Other supplementation studies similarly increased circulating HEPEs (including 18-HEPE) and EPA-derived epoxide metabolites.

Important interpretive limits

• The ratio does not measure membrane phospholipid release, cell-specific cyclooxygenase/lipoxygenase activity, or actual production of inflammatory or pro-resolving mediators. A high ratio therefore does not establish that inflammatory mediators are elevated or that resolution is impaired.
• “Resolving mediators” should not be equated solely with EPA: EPA is a precursor for E-series resolvins, whereas DHA is the principal precursor of D-series resolvins, protectins, and maresins; AA can also form lipoxins. Notably, resolvins were not detected in one supplementation study despite increased EPA-related precursor signals.

Bottom line

• A high AA:EPA ratio validly indicates an AA-skewed relative substrate pool compared with EPA, but it is not proof of heightened inflammation or deficient resolution. For clinically meaningful inference—particularly in an older adult—interpret the specific sampled compartment and pair the ratio with clinical context and, when needed, targeted lipid-mediator measurements.